Mark Jeye

Mark Jeye is an experienced professional in portfolio management and program development with a strong focus on cell and gene therapy. Currently serving as Principal Portfolio Manager and Portfolio Leader for Cell & Gene Therapy at Cytiva since April 2020, Mark previously held the role of Portfolio Leader for Cell & Gene Therapy at GE Healthcare from November 2015 to April 2020. Mark's career also includes significant positions at Cobham Defense Systems, Thermo Fisher Scientific, Brooks Automation, PRI Automation, and Raytheon, with responsibilities ranging from program management to engineering leadership. Mark holds a degree from the University of Massachusetts Amherst, earned between 1978 and 1983, and graduated from Holliston High School.